Poster Session II – Poster of Distinction II - A215 ASSOCIATION BETWEEN CROHN’S DISEASE POLYGENIC RISK SCORE AND GUT MICROBIOME IN HEALTHY FIRST-DEGREE RELATIVES

Abstract Background Crohn’s Disease (CD) is characterized by a chronic, relapsing inflammation of the intestine of unknown cause. The current hypothesis is that microbial or environmental factors induce gut inflammation in genetically susceptible individuals, leading to chronic intestinal inflammation. The association between CD genetic risk and the gut microbiome as it relates to risk of CD development remains unclear. Aims To investigate whether CD polygenic risk score (PRS) can predict CD onset and whether host genetic susceptibility to CD is associated with alterations in gut microbiome in first-degree relatives (FDRs). Methods Stool samples and clinical metadata were collected from 2753 healthy FDRs of CD patients in the GEM cohort. Host genotype was measured using Immunochip, Exomechip and the Illumina Global Screening Array chip and imputed using the TOPMed Imputation Server. A CD-polygenic risk score (PRS) was derived based on previous IBD GWAS summary statistics. Subjects were stratified into quartiles (Q1-Q4) based on their PRS, with Q4 representing the highest PRS. 16S rRNA gene amplicon sequencing was performed to determine the relative abundance of genus-level taxa using the DADA2 pipeline. Fecal calprotectin (FCP) was measured by ELISA. Results Among 2753 healthy FDRs, 78 developed CD during a median of 3.4 years from recruitment. Subjects in Q4 of the CD-PRS were more likely to develop CD than those in Q1: HR = 3.76 (95% CI: 1.73-8.17, p = 0.001). After adjusting for FCP, the increased risk remained significant for Q4 vs Q1 (HR = 2.23, 95% CI: 1.01-4.95, p = 0.048). No significant difference in Shannon alpha diversity was observed across PRS quartiles (p = 0.155). PERMANOVA indicated that PRS explained only 0.13% of beta diversity variation. CD PRS was associated with lower prevalence of Izemoplasmatales, and Oscillospiraceae pseudoflavonifractor, Peptococcaceae uncultured, Lachnospiraceae roseburia, Ruminococcaceae, Oscillospiraceae UCG-005, and Oscillospiraceae UCG-003 and higher prevalence of Carnobacteriaceae granulicatella (q < 0.05). None of the taxa significantly modified or mediated the relationship between PRS and CD risk. Conclusions CD-PRS is significantly associated with increased risk of CD among FDRs, but not with gut microbial alpha or beta diversity. While certain individual taxa are associated with higher PRS, there was no evidence of interaction or mediating effect of the gut microbiome with PRS on CD risk. Funding Agencies CCC, CIHRHelmsley Charitable Trust

Authors

Institutions

Publication Details

Journal
Journal of the Canadian Association of Gastroenterology
Published
2026-02-01
DOI
https://doi.org/10.1093/jcag/gwaf042.214
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Poster Session II – Poster of Distinction II - A215 ASSOCIATION BETWEEN CROHN’S DISEASE POLYGENIC RISK SCORE AND GUT MICROBIOME IN HEALTHY FIRST-DEGREE RELATIVES

Osvaldo Espin Garcia, Dalin Li, Maham Bushra, R Chen et al.
Journal of the Canadian Association of Gastroenterology
Inflammatory Bowel Disease
article

Poster Session II – Poster of Distinction II - A215 ASSOCIATION BETWEEN CROHN’S DISEASE POLYGENIC RISK SCORE AND GUT MICROBIOME IN HEALTHY FIRST-DEGREE RELATIVES

Osvaldo Espin Garcia, Dalin Li, Maham Bushra, R Chen, H Steinhart, S Lee, S Zezos, Q Li, H Q Huynh, K Croitoru, K Jacobson, R Panaccione, A Griffiths, L Chen, W Turpin
article en

Abstract

Abstract Background Crohn’s Disease (CD) is characterized by a chronic, relapsing inflammation of the intestine of unknown cause. The current hypothesis is that microbial or environmental factors induce gut inflammation in genetically susceptible individuals, leading to chronic intestinal inflammation. The association between CD genetic risk and the gut microbiome as it relates to risk of CD development remains unclear. Aims To investigate whether CD polygenic risk score (PRS) can predict CD onset and whether host genetic susceptibility to CD is associated with alterations in gut microbiome in first-degree relatives (FDRs). Methods Stool samples and clinical metadata were collected from 2753 healthy FDRs of CD patients in the GEM cohort. Host genotype was measured using Immunochip, Exomechip and the Illumina Global Screening Array chip and imputed using the TOPMed Imputation Server. A CD-polygenic risk score (PRS) was derived based on previous IBD GWAS summary statistics. Subjects were stratified into quartiles (Q1-Q4) based on their PRS, with Q4 representing the highest PRS. 16S rRNA gene amplicon sequencing was performed to determine the relative abundance of genus-level taxa using the DADA2 pipeline. Fecal calprotectin (FCP) was measured by ELISA. Results Among 2753 healthy FDRs, 78 developed CD during a median of 3.4 years from recruitment. Subjects in Q4 of the CD-PRS were more likely to develop CD than those in Q1: HR = 3.76 (95% CI: 1.73-8.17, p = 0.001). After adjusting for FCP, the increased risk remained significant for Q4 vs Q1 (HR = 2.23, 95% CI: 1.01-4.95, p = 0.048). No significant difference in Shannon alpha diversity was observed across PRS quartiles (p = 0.155). PERMANOVA indicated that PRS explained only 0.13% of beta diversity variation. CD PRS was associated with lower prevalence of Izemoplasmatales, and Oscillospiraceae pseudoflavonifractor, Peptococcaceae uncultured, Lachnospiraceae roseburia, Ruminococcaceae, Oscillospiraceae UCG-005, and Oscillospiraceae UCG-003 and higher prevalence of Carnobacteriaceae granulicatella (q < 0.05). None of the taxa significantly modified or mediated the relationship between PRS and CD risk. Conclusions CD-PRS is significantly associated with increased risk of CD among FDRs, but not with gut microbial alpha or beta diversity. While certain individual taxa are associated with higher PRS, there was no evidence of interaction or mediating effect of the gut microbiome with PRS on CD risk. Funding Agencies CCC, CIHRHelmsley Charitable Trust

Journal of the Canadian Association of GastroenterologyVol. 9(Supplement_1)
Rutgers, The State University of New Jersey (US), Western University (CA), Cedars-Sinai Medical Center (US), University of Alberta (CA), University of Calgary (CA), University of Toronto (CA), Lunenfeld-Tanenbaum Research Institute (CA), Hospital for Sick Children (CA), Johnson University (US), BC Children's Hospital (CA)
Openalex Percentile: Top 54%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.